PureTech Health (PRTC) Operating Leases (2019 - 2025)

PureTech Health (PRTC) has 7 years of Operating Leases data on file, last reported at $11.1 million in Q4 2025.

• Quarterly Operating Leases fell 24.43% year-over-year to $11.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.1 million (down 24.43% YoY) and the FY2025 annual result came in at $11.1 million, down 24.43% from the prior year.
• Operating Leases retreated to $11.1 million in Q4 2025 per PRTC's latest filing, from $12.9 million in the prior quarter.
• Across five years, Operating Leases topped out at $33.0 million in Q4 2021 and bottomed at $11.1 million in Q4 2025.
• The 5-year median for Operating Leases is $18.2 million (2023), against an average of $20.4 million.
• The widest annual swing landed in 2021, when Operating Leases slipped 6.67%; it then tumbled 32.22% in 2024.
• Tracing PRTC's Operating Leases over 5 years: stood at $33.0 million in 2021, then retreated by 11.71% to $29.1 million in 2022, then declined by 25.69% to $21.6 million in 2023, then tumbled by 32.22% to $14.7 million in 2024, then retreated by 24.43% to $11.1 million in 2025.
• Per Business Quant, the three latest PRTC Operating Leases figures stand at $11.1 million (Q4 2025), $12.9 million (Q2 2025), and $14.7 million (Q4 2024).

Peer Comparison